- $525.56m
- $985.23m
- $1.08bn
U.S. STOCKS ON THE MOVE-Regeneron, Elf Beauty, Eli Lilly
U.S. STOCKS ON THE MOVE-Oruka Therapeutics, Regeneron, natgas companies
Adtran falls after boosted $175 mln convertible bonds sale
Brief: Adtran Prices Its Offering Of $175 Million Aggregate Principal Amount Of 3.75 % Convertible Senior Notes Due 2030
Adtran tumbles after unveiling $150 mln convertible bonds sale
Brief: Adtran Holdings Announces Proposed Convertible Senior Notes Offering
Adtran drops after $150 mln convertible bonds sale unveil
Adtran Holdings Inc Reports Results For The Quarter Ended June 30: Earnings Summary
Brief: Adtran Says Q2 Revenue $265.068 Million
Adtran Holdings Inc Expected To Post Earnings Of 1 Cent A Share: Earnings Preview
Brief: Adtran Holdings Inc Says Files Non-Timely 10-Q With U.S. SEC
Adtran Holdings Inc Reports Results For The Quarter Ended March 31: Earnings Summary
Brief: ADTRAN Q1 Adjusted EPS USD 0.03 Vs. IBES Estimate USD -0.03
Adtran Holdings Inc Expected To Post A Loss Of 3 Cents A Share: Earnings Preview
Brief: Adtran Holdings Inc Announces CFO Transition
Adtran Holdings Inc Reports Results For The Quarter Ended December 31: Earnings Summary
Brief: Adtran Holdings Says Q4 GAAP Diluted Loss Per Share $0.58, Non-GAAP EPS $0.00
Adtran Holdings Inc Expected To Post A Loss Of 3 Cents A Share: Earnings Preview
Adtran Holdings Inc Reports Results For The Quarter Ended In September 30: Earnings Summary